These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24005026)

  • 1. Evaluation of circulating osteopontin levels in an unselected cohort of patients with multiple sclerosis: relevance for biomarker development.
    Kivisäkk P; Healy BC; Francois K; Gandhi R; Gholipour T; Egorova S; Sevdalinova V; Quintana F; Chitnis T; Weiner HL; Khoury SJ
    Mult Scler; 2014 Apr; 20(4):438-44. PubMed ID: 24005026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma osteopontin levels are associated with disease activity in the patients with multiple sclerosis and neuromyelitis optica.
    Shimizu Y; Ota K; Ikeguchi R; Kubo S; Kabasawa C; Uchiyama S
    J Neuroimmunol; 2013 Oct; 263(1-2):148-51. PubMed ID: 23910387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specificity and correlation with disease activity of cerebrospinal fluid osteopontin levels in patients with multiple sclerosis.
    Chowdhury SA; Lin J; Sadiq SA
    Arch Neurol; 2008 Feb; 65(2):232-5. PubMed ID: 18268193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma osteopontin levels in multiple sclerosis.
    Comabella M; Pericot I; Goertsches R; Nos C; Castillo M; Blas Navarro J; Río J; Montalban X
    J Neuroimmunol; 2005 Jan; 158(1-2):231-9. PubMed ID: 15589058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated osteopontin levels in active relapsing-remitting multiple sclerosis.
    Vogt MH; Lopatinskaya L; Smits M; Polman CH; Nagelkerken L
    Ann Neurol; 2003 Jun; 53(6):819-22. PubMed ID: 12783433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteopontin concentrations are increased in cerebrospinal fluid during attacks of multiple sclerosis.
    Börnsen L; Khademi M; Olsson T; Sørensen PS; Sellebjerg F
    Mult Scler; 2011 Jan; 17(1):32-42. PubMed ID: 20921238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of plasma Osteopontin level in relapsing- remitting multiple sclerosis patients compared to healthy subjects in Isfahan Province.
    Jafarinia M; Sadeghi E; Alsahebfosoul F; Etemadifar M; Jahanbani-Ardakani H
    Int J Neurosci; 2020 May; 130(5):493-498. PubMed ID: 31795798
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment patterns in disease-modifying therapy for patients with multiple sclerosis in the United States.
    Bonafede MM; Johnson BH; Wenten M; Watson C
    Clin Ther; 2013 Oct; 35(10):1501-12. PubMed ID: 24139422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased levels of IL-23 and osteopontin in serum and cerebrospinal fluid of multiple sclerosis patients.
    Wen SR; Liu GJ; Feng RN; Gong FC; Zhong H; Duan SR; Bi S
    J Neuroimmunol; 2012 Mar; 244(1-2):94-6. PubMed ID: 22329905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteopontin levels and increased disease activity in relapsing-remitting multiple sclerosis patients.
    Vogt MH; Floris S; Killestein J; Knol DL; Smits M; Barkhof F; Polman CH; Nagelkerken L
    J Neuroimmunol; 2004 Oct; 155(1-2):155-60. PubMed ID: 15342207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF inflammation and axonal damage are increased and correlate in progressive multiple sclerosis.
    Romme Christensen J; Börnsen L; Khademi M; Olsson T; Jensen PE; Sørensen PS; Sellebjerg F
    Mult Scler; 2013 Jun; 19(7):877-84. PubMed ID: 23178691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical significance of serum osteopontin in patients with multiple myeloma].
    Kang SY; Lee JJ; Lee WI
    Korean J Lab Med; 2007 Dec; 27(6):400-5. PubMed ID: 18160829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteopontin (OPN) as a CSF and blood biomarker for multiple sclerosis: A systematic review and meta-analysis.
    Agah E; Zardoui A; Saghazadeh A; Ahmadi M; Tafakhori A; Rezaei N
    PLoS One; 2018; 13(1):e0190252. PubMed ID: 29346446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased plasma osteopontin in frequent exacerbator and acute exacerbation of COPD.
    Lee SJ; Kim SH; Kim W; Lim S; Lee SH; Kim YE; Cho YJ; Jeong YY; Kim HC; Lee JD; Hwang YS
    Clin Respir J; 2014 Jul; 8(3):305-11. PubMed ID: 24188595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The improvement of cognitive functions is associated with a decrease of plasma Osteopontin levels in Natalizumab treated relapsing multiple sclerosis.
    Iaffaldano P; Ruggieri M; Viterbo RG; Mastrapasqua M; Trojano M
    Brain Behav Immun; 2014 Jan; 35():176-81. PubMed ID: 23994630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical relevance of serum natalizumab concentration and anti-natalizumab antibodies in multiple sclerosis.
    Vennegoor A; Rispens T; Strijbis EM; Seewann A; Uitdehaag BM; Balk LJ; Barkhof F; Polman CH; Wolbink G; Killestein J
    Mult Scler; 2013 Apr; 19(5):593-600. PubMed ID: 22992450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease modifying drugs modulate endogenous secretory receptor for advanced glycation end-products, a new biomarker of clinical relapse in multiple sclerosis.
    Sternberg Z; Sternberg D; Drake A; Chichelli T; Yu J; Hojnacki D
    J Neuroimmunol; 2014 Sep; 274(1-2):197-201. PubMed ID: 25064498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated plasma osteopontin level is predictive of cirrhosis in patients with hepatitis B infection.
    Zhao L; Li T; Wang Y; Pan Y; Ning H; Hui X; Xie H; Wang J; Han Y; Liu Z; Fan D
    Int J Clin Pract; 2008 Jul; 62(7):1056-62. PubMed ID: 17537188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between circulating full-length osteopontin and IFN-gamma with disease status of tuberculosis and response to successful treatment.
    Ridruechai C; Sakurada S; Yanai H; Yamada N; Kantipong P; Piyaworawong S; Dhepakson P; Khusmith S; Keicho N
    Southeast Asian J Trop Med Public Health; 2011 Jul; 42(4):876-89. PubMed ID: 22299470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Assessment of osteopontin and osteoprotegerin levels in abdominal aortic aneurysm patients].
    Czyzewska-Buczyńska A; Zuk N; Bałasz S; Witkiewicz W
    Przegl Lek; 2013; 70(3):102-5. PubMed ID: 24003660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.